Navigation Links
Danaher Announces Executive Appointments
Date:4/5/2011

WASHINGTON, April 5, 2011 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that Henk van Duijnhoven has been promoted to Senior Vice President and Amir Aghdaei and Henrik Roos have each been appointed Vice President and Group Executive of Danaher.

In his new role, Henk van Duijnhoven will have responsibility for Danaher's Dental segment, which includes KaVo Group and Sybron Dental Specialties.  Danaher's Dental segment generated $1.8 billion of revenue in 2010.  He will report directly to H. Lawrence Culp, Jr., President and Chief Executive Officer of Danaher.  Henk joined Danaher in 2002 as Vice President, Business Development for Product Identification.  During his time at Danaher, he has served as General Manager of Videojet EMEA, Managing Director of Linx, and Vice President, Human Resources for Danaher.  In 2008, Henk was appointed Group Executive of KaVo Group and President of KaVo Worldwide.  Henk holds a BS in Automotive Engineering from Hogere Technische School, The Netherlands and an MBA from the Massachusetts Institute of Technology, Sloan School of Management.  

Amir Aghdaei joined Danaher in 2009 as President of Tektronix.  During his time with Danaher, Amir has been instrumental in driving core growth and improving performance at Tektronix and in building out Danaher's Test & Measurement segment through acquisition.  He has more than 20 years of experience in the test and measurement industry.  Amir earned an MBA from the University of Delaware, Masters of Science from Georgia State University and a Bachelors of Science Degree in Industrial Engineering from the University of Iran.

Henrik Roos joined Danaher in November 2009 via the PaloDEx acquisition where he was the President and Chief Executive Officer. Most recently he has served as the President of KaVo's Imaging Group where he had responsibility for leading Danaher's dental imaging businesses globally. Henrik brings over 20 years of Dental industry experience to Danaher. In addition to his imaging responsibilities, Henrik will now have responsibility for all of Danaher's North American dental equipment businesses, including Pelton & Crane.  Henrik holds a MS in Engineering from the University of Technology, Helsinki.  

Mr. Culp stated, "I am pleased to be able to make these key leadership appointments with candidates from within Danaher, which I believe is a testament to the strength and depth of our management team. Henk, Amir and Henrik have consistently demonstrated superior leadership and have been key contributors to Danaher's growth.  I am confident that they are well-equipped to take on the additional responsibilities of their new roles and that they will continue to make instrumental contributions as we continue to build a premier global enterprise."  

Danaher is a diversified technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers.  Our portfolio of premier brands is among the most highly recognized in each of the markets we serve.  Driven by a foundation provided by the Danaher Business System, our 48,000 associates serve customers in more than 125 countries and generated $13.2 billion of revenue in 2010. For more information please visit our website: www.danaher.com.


'/>"/>
SOURCE Danaher Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thoratec Announces Early Termination of HSR Waiting Period for the Sale of ITC to Danaher Corporation
2. Danaher Reports Record Third Quarter 2010 Results
3. Danaher to Present at Upcoming Industry Conferences
4. Danaher to Acquire Beckman Coulter, Inc.
5. Beckman Coulters Board of Directors Recommends Stockholders Accept Danahers Cash Tender Offer
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Health and Gateway Health proudly announce a dynamic collaboration that ... plan members with specific high risk needs. In ... group of consumers, Wellbridge combines technology and population expertise with ... members, daily behaviors and lifestyle. ... , , ...
(Date:12/5/2016)...  New research by the CVS Health (NYSE: ... U.S. Department of Health and Human Services, Office ... (ASPR), published online today in JAMA Internal ... patients with chronic conditions to refill medications prior ... affirms that public-private partnerships can facilitate timely pharmacy ...
(Date:12/5/2016)... 5, 2016  BD (Becton, Dickinson and Company) (NYSE: ... company, will demonstrate an enhanced technology platform designed with ... the company,s leading Pyxis™ and Alaris™ systems, at this ... Midyear Meeting being held in Las ... national data show that approximately 68 percent of medication ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... 03, 2016 , ... Penrose Senior Care Auditors® was announced ... evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony and Banquet ... for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ingenuity, commitment ...
(Date:12/4/2016)... , ... December 04, 2016 , ... ... major cosmetic surgery can now take advantage of a cosmetic procedure known as ... rejuvenation treatment that reduces the appearance of age spots, fine lines, uneven ...
(Date:12/4/2016)... PITTSBURGH, PA (PRWEB) , ... December 04, 2016 , ... ... not enough. One must brush properly to achieve optimal results. This important necessity inspired ... saw a need for a way to ensure that people break or avoid bad ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in ... Conference Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New ... Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and ...
(Date:12/2/2016)... DIEGO, Calif. (PRWEB) , ... December 02, 2016 , ... ... Event at the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals ... myeloproliferative neoplasms (MPNs) by going above and beyond the standard of care, demonstrating leadership ...
Breaking Medicine News(10 mins):